mRNA expression of TLR2 in tumor-infiltrating CD8+ T cells was remarkable decreased in comparison with that in peripheral CD8+ T cells from NCs (LSD-t test, P < 0.01, Fig. 1) and from GC patients (LSD-t test, P < 0.05, Fig. 1). This evidence concerns the gene TLR2 and gastric cancer.